Yannis Jemiai

Chief Scientific Officer

Yannis is an experienced statistician who has led the development of Cytel’s software and strategic consulting offerings for nearly 20 years. In his current role as Chief Scientific Officer, Yannis has oversight of the corporate-level scientific agenda. This includes research portfolios in complex and innovative clinical trial designs, Bayesian methods, platform trials and master protocols, and advanced uses of real-world evidence to strengthen regulatory submissions. His research interests include causal inference, adaptive trial design, financial and clinical strategy, statistical computing and regulatory affairs.

Yannis also sets the vision and guides the development of ​​Cytel’s software products, ensuring that our team’s prolific scientific innovations are rapidly made available to clients. This includes ​​Solara®, a trial strategy platform that enables teams to confidently align on the optimal design, as well as our industry-leading statistical design packages ​​East and Compass, and exact statistics applications ​​StatXact® and LogXact®.

Yannis’s research has been published in numerous statistical journals. He earned his Ph.D. in Biostatistics from Harvard University, an M.P.H. from Columbia University, and a B.A. in Molecular and Cellular Biology, also from Harvard.